-- Termination of the Forward Purchase Agreements simplifies AEON's capitalization structure --
-- AEON to expand its Board of Directors with appointment of candidate selected by its strategic partner following full funding of transaction --
AEON Biopharma Announces $15M Financing Transaction And Termination Of Forward Purchase Agreements
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.